Fleur Krommendijk: Donor Acceptance of Iron Supplementation Across Seven Countries
Fleur Krommendijk, Radiology Technician at OLVG, posted on LinkedIn about a recent article she and her colleagues co-authored, adding:
”Proud to share that research from my master’s thesis has now been published in Transfusion Medicine Reviews.
This study, conducted at Sanquin Blood Bank, explores donor acceptance of iron supplementation across seven countries.
Key finding: over 80% of donors were willing to take postdonation iron supplements, with willingness strongly associated with trust in the blood service and prior supplement use, but not with donor knowledge.
I am very grateful to Amber Meulenbeld and Katja van den Hurk for their excellent supervision and guidance throughout this project.
Title: Knowledge Related to Blood Donation and Iron, and Willingness to Take Iron Supplements Among Blood Donors in Multiple Countries
Authors: Fleur Krommendijk, Amber Meulenbeld, Jan Karregat, Bryan R. Spencer, Fredrik Toss, Noriko Namba, Nelson Tsuno, Klara Greffin, Konstanze Aurich, Eva-Maria Merz, Mindy Goldman, Eamonn Ferguson, Trynke Hoekstra, Mikko Arvas, Katja van den Hurk
Read the Full Article on Transfusion Medicine Reviews

Stay updated with Hemostasis Today.
-
Mar 24, 2026, 17:12Ron DePinho: CRISPR Progress in Cellular Immunotherapy
-
Mar 24, 2026, 17:12Martine Gilard։ Women’s Heart Health as a National Priority
-
Mar 24, 2026, 17:11Erik Nelson։ Blood Vessels – The Silent System That Determines How You Age
-
Mar 24, 2026, 17:10Anthony Yazbeck: Why the Hemolysin Test Matters More Than You Think
-
Mar 24, 2026, 17:09Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
-
Mar 24, 2026, 17:06Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
-
Mar 24, 2026, 17:01Victor Canata: Is Embolectomy the Best Treatment for Pulmonary Thromboembolism?
-
Mar 24, 2026, 16:57Hossam Qassem: The Stepwise Investigation Framework for ICU Hemoglobin Drop
-
Mar 24, 2026, 16:56Alan Nurden: Targeting Splice Site Variants in Alport Syndrome with Antisense Therapy